Randomized controlled trial of irinotecan drug-eluting beads with simultaneous FOLFOX and bevacizumab for patients with unresectable colorectal liver-limited metastasis

Sorafenib or placebo in combination with transarterial chemoembolization (TACE) with doxorubicin-eluting beads (DEBDOX) for intermediate-stage hepatocellular carcinoma (HCC): Phase II, randomized, double-blind SPACE trial.

(2017) Riccardo Lencioni et al.   JOURNAL OF CLINICAL ONCOLOGY

Transarterial Treatment of Colorectal Cancer Liver Metastases with Irinotecan-Loaded Drug-Eluting Beads: Technical Recommendations

(2014) Riccardo Lencioni et al.   JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY

Assessment of Chemotherapy Response in Colorectal Liver Metastases in Patients Undergoing Hepatic Resection and the Correlation to Pathologic Residual Viable Tumor

(2013) Michael E. Egger et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

Response Evaluation in Patients With Colorectal Liver Metastases: RECIST Version 1.1 Versus Modified CT Criteria

(2012) Woo-Suk Chung et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

mRECIST and EASL responses at early time point by contrast-enhanced dynamic MRI predict survival in patients with unresectable hepatocellular carcinoma (HCC) treated by doxorubicin drug-eluting beads transarterial chemoembolization (DEB TACE)

(2012) H. J. Prajapati et al.   ANNALS OF ONCOLOGY

Irinotecan Drug-Eluting Beads in the Treatment of Chemo-Naive Unresectable Colorectal Liver Metastasis with Concomitant Systemic Fluorouracil and Oxaliplatin: Results of Pharmacokinetics and Phase I Trial

(2012) Robert C. G. Martin et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statement

(2012) Roderich E. Schwarz et al.   HPB

High Survival Rate After Two-Stage Resection of Advanced Colorectal Liver Metastases: Response-Based Selection and Complete Resection Define Outcome

(2011) Antoine Brouquet et al.   JOURNAL OF CLINICAL ONCOLOGY

Liver Resection for Colorectal Metastases in Presence of Extrahepatic Disease: Results from an International Multi-institutional Analysis

(2010) Carlo Pulitanò et al.   ANNALS OF SURGICAL ONCOLOGY

Hepatic Intra-Arterial Injection of Drug-Eluting Bead, Irinotecan (DEBIRI) in Unresectable Colorectal Liver Metastases Refractory to Systemic Chemotherapy: Results of Multi-Institutional Study

(2010) Robert C. G. Martin et al.   ANNALS OF SURGICAL ONCOLOGY

Toxicity of Irinotecan-Eluting Beads in the Treatment of Hepatic Malignancies: Results of a Multi-Institutional Registry

(2010) R. C. G. Martin et al.   CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY

Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma

(2010) Riccardo Lencioni et al.   SEMINARS IN LIVER DISEASE

Sinusoidal Injury Increases Morbidity After Major Hepatectomy in Patients With Colorectal Liver Metastases Receiving Preoperative Chemotherapy

(2009) Hiroshi Nakano et al.   ANNALS OF SURGERY

Conversion to Resectability Using Hepatic Artery Infusion Plus Systemic Chemotherapy for the Treatment of Unresectable Liver Metastases From Colorectal Carcinoma

(2009) Nancy E. Kemeny et al.   JOURNAL OF CLINICAL ONCOLOGY

Transarterial chemoembolisation (TACE) using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim report

(2009) Robert CG Martin et al.   World Journal of Surgical Oncology

Transarterial Chemoembolization of Metastatic Colorectal Carcinoma with Drug-Eluting Beads, Irinotecan (DEBIRI): Multi-Institutional Registry

(2009) Robert C. G. Martin et al.   Journal of Oncology

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

(2008) Bernard Nordlinger et al.   LANCET